Dr. Stephan Brand
Claim this profileCantonal Hospital St.Gallen
Studies Crohn's Disease
Studies Colitis
5 reported clinical trials
3 drugs studied
Clinical Trials Stephan Brand is currently running
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
TAK-279
for Crohn's Disease
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate medical problems. An endoscopy will be used to check the bowel for inflammation. The participants will be treated with TAK-279 for 52 weeks (1 year). During the study, participants will visit their study clinic 15 times.
Recruiting0 awards Phase 2
More about Stephan Brand
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Stephan Brand has experience with
- Mirikizumab
- Vedolizumab
- TAK-279
Breakdown of trials Stephan Brand has run
Crohn's Disease
Colitis
Ulcerative Colitis
Oral Ulcers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephan Brand specialize in?
Stephan Brand focuses on Crohn's Disease and Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Stephan Brand currently recruiting for clinical trials?
Yes, Stephan Brand is currently recruiting for 2 clinical trials in St. Gallen Sankt Gallen. If you're interested in participating, you should apply.
Are there any treatments that Stephan Brand has studied deeply?
Yes, Stephan Brand has studied treatments such as Mirikizumab, Vedolizumab, TAK-279.
What is the best way to schedule an appointment with Stephan Brand?
Apply for one of the trials that Stephan Brand is conducting.
What is the office address of Stephan Brand?
The office of Stephan Brand is located at: Cantonal Hospital St.Gallen, St. Gallen, Sankt Gallen 9007 Switzerland. This is the address for their practice at the Cantonal Hospital St.Gallen.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.